School of Medicine


Showing 81-100 of 136 Results

  • Julie Parsonnet

    Julie Parsonnet

    George DeForest Barnett Professor of Medicine and Professor of Epidemiology and Population Health

    Current Research and Scholarly InterestsI am an infectious diseases epidemiologist who has done large field studies in both the US and developing countries. We research the long-term consequences of chronic interactions between the human host and the microbial world. My lab has done fundamental work establishing the role of H. pylori in causing disease and understanding its epidemiology. Currently, our research dissects how and when children first encounter microbes and the long term effects of these exposures on health.

  • Ruoxi Pi

    Ruoxi Pi

    Postdoctoral Scholar, Infectious Diseases

    BioI received my BS in Biological Sciences in Zhejiang University in China, where I conducted research in polyphasic taxonomy in anaerobic bacteria. I received my PhD in Yale University, where I studied the early events of retrovirus infection in animal models. Now in the Blish lab, I am investigating NK cell responses during HIV-1 infection and trying to manipulate the NK cells to target latently infected cells.

  • Benjamin Pinsky

    Benjamin Pinsky

    Professor of Pathology, of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases)

    Current Research and Scholarly InterestsDevelopment and application of molecular assays for the diagnosis and management of infectious diseases.

  • Orlando Quintero, MD

    Orlando Quintero, MD

    Clinical Assistant Professor, Medicine - Infectious Diseases

    BioDr. Orlando Quintero is a board-certified, fellowship trained internist specializing in the diagnosis and treatment of infectious diseases. He is also clinical assistant professor in the Department of Medicine, Division of Infectious Diseases, at Stanford University School of Medicine.

    As a clinician, Dr. Quintero diagnoses and treats infectious diseases in immunocompromised patients. This includes the prevention, diagnosis and treatment of infections in patients who are immunosuppressed because of Solid Organ Transplantation, Bone Marrow (Hematopoeitic Cell) Transplants, Hematologic Malignancies, Chemotherapy for Solid Tumors, HIV who receive Chemotherapy, Solid Organ or Bone Marrow Transplants Immunomodulators for Auto-Immune Diseases and other forms of immunodeficiency.

    Dr. Quintero has published on topics including coronavirus in kidney transplant patients, prevention of cytomegalovirus in heart transplant patients, and prevention of urinary tract infections in renal transplant patients. His work has appeared in publications including Transplant Infectious Disease, Emerging Infectious Diseases, and the Journal of Heart and Lung Transplantation.

    He has delivered presentations at meetings of organizations including the International Society for Heart and Lung Transplantation, Interscience Conference on Antimicrobial Agents and Chemotherapy, and American Society of Tropical Medicine and Hygiene. Topics of his presentations have included prevention of cytomegalovirus, prevention of recurrent urinary tract infections, Chagas disease in New York City, and more.

    Currently, Dr. Quintero is conducting research on treatment of patients with COVID-19, prevention and treatment of invasive fungal infections of the gastrointestinal tract in immunocompromised patients, and the epidemiology of invasive fungal infections in heart transplant recipients.

    Among his awards, He has received honors for his teaching and research from Albert Einstein College. He also has earned recognition from the Fred Hutchinson Cancer Research Center and the American Society of Transplantation.

    Dr. Quintero’s volunteer community service includes participation in health fairs to promote HIV testing and hypertension control, plus disease management in the Garifuna population in New York – descendants of an Afro-indigenous population from the Caribbean island of St. Vincent.

    He is a member of the Infectious Disease Society of American, Infectious Diseases Association of California, American Society of Transplantation, and HIV Medicine Association.

  • David A. Relman

    David A. Relman

    Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology
    On Leave from 01/15/2024 To 12/20/2024

    Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.

  • Cybele A. Renault, MD, DTM&H, FIDSA

    Cybele A. Renault, MD, DTM&H, FIDSA

    Clinical Associate Professor, Medicine - Infectious Diseases

    BioDr. Renault has devoted her career to caring for vulnerable patient populations, both domestically and overseas. She completed her medical school and residency training at the University of Chicago, caring for underserved patients on Chicago's South Side, followed by a Chief Resident year at John H. Stroger, Jr. Hospital of Cook County, the public hospital serving the uninsured in Chicago. She began her career in global health as an Infectious Diseases fellow at Stanford, validating low-cost HIV diagnostics in Burkina Faso, and providing clinical service and teaching in India and Zimbabwe as a fellow, and later in Thailand, Uganda, Rwanda and Kenya as one of our Infectious Diseases faculty. Her clinical work is focused on caring for our veteran population, working to empower veterans to engage in their care, often in the setting of significant mental illness.

    Dr. Renault is most passionate about medical education and program development to combat global antimicrobial resistance through antimicrobial stewardship, to create opportunities for the Internal Medicine residents centering on caring for vulnerable patient populations, and to develop impactful and sustainable programs in collaboration with our low- and middle-income partners for our Center for Innovation in Global Health. She served as Associate Program Director for the Internal Medicine Residency Program for 4 years prior to transitioning to her current role as Program Lead for Global Health, for which she leads the Global Health Track for the Internal Medicine residency program and develops global health initiatives for the Department of Medicine. She co-founded and has been director of the Stanford 2-week intensive global health course since its inception in 2012, she has structured trainee and faculty rotations based on evolving needs of our partner sites in Uganda, Rwanda, Zimbabwe and Sri Lanka, she is the faculty lead for the ID/antimicrobial stewardship partnership between Stanford and Moi Teaching and Referral Hospital in Eldoret, Kenya, and she is leading Stanford's Internal Medicine virtual case-based education initiative to support our newest medical school partner in Negele Arsi, Ethiopia.

    Dr. Renault strives to augment Stanford's contributions and support for underserved patient populations in the United States. She established resident rotations in Shiprock, New Mexico and Chinle, Arizona through the Indian Health Service, and she is Faculty Advisor for the Internal Medicine Health Equity, Advocacy and Research concentration in the residency program. She also aspires to improve resources for women physicians. In 2016, Dr. Renault established the GME Women in Medicine Leadership Council, with the intention of creating community and encouraging conversations about professional and personal life decisions as women in the field of medicine. She is passionate about mentoring through sharing personal experiences, creating an environment that encourages reflection, and building skills to address challenges unique to women in medicine.

    In 2022, in recognition of her passion for medical education and her success in program development, Dr. Renault was asked to join the leadership at Palo Alto Veterans Health Care System as Deputy Associate Chief of Staff for Education. In this role, she works with rotation directors to optimize their respective rotations to offer robust educational opportunities for trainees across specialties who are rotating at the Palo Alto VA.

  • Izabela Mauricio Rezende

    Izabela Mauricio Rezende

    Postdoctoral Scholar, Infectious Diseases

    BioI have a B.S. in Biology, M.Sc. in Immunology and Infectious diseases, Ph.D. in Microbiology. I am currently a Postdoctoral Researcher at the Stanford University School of Medicine, working with Dr. Jason Andrews at the new Stanford Pandemic Preparedness Hub, a fellowship I was awarded at the end of 2022. As part of a pandemic preparedness, We are tytrying to understand the potential viruses at risk of pandemic spread. Using disease modeling, epidemiological, and phylogenetic analysis, we study the genomic evolution and transmission dynamics of H5N1 avian influenza A after 2020.

    I am in my third postdoctoral year at Stanford and completed the first two years with Dr. Desiree LaBeaud. I have a Ph.D. in Microbiology, with an emphasis in Virology, and a Master’s in Infectious Diseases. . My Ph.D. was conducted in Brazil, under the supervision of Dr. Betânia Drumond, and contemplated the virological and epidemiological aspects of yellow fever (YF) outbreak in Minas Gerais/BR in 2017-2018, combining laboratory, clinical, and data analysis (publications: DOI 10.1126/science.aat7115; DOI 10.1371/journal.pntd.0006538; DOI 10.1128/jcm.00254-22; DOI 10.3390/vaccines7040206; DOI 10.1186/s12985-019-1277-7). I came to Stanford University for my first postdoc with Dr. Desiree LaBeaud. For two years, I led an international NIH R01 project investigating the dynamics of the biggest YF outbreak in Brazil, including the description of a new syndrome, Late-relapsing hepatitis after yellow fever (DOI 10.3390/v12020222), and risk factors for severe YF. I was also involved in other projects regarding SARS-CoV-2 variants and disease severity in infants (DOI 10.3389/fmed.2022.896352), Rift Valley fever virus epidemiology in humans and animals in Kenya (DOI 10.1371/journal.pgph.0000505), and dengue virus evolution in Africa (ongoing Ph.D. candidate mentorship).

    During the COVID-19 pandemic, we also supported the Brazilian Ministry of Health with the SARS-CoV-2 diagnosis in human samples and also in the investigation of the SARS-CoV-2 RNA in surfaces of density public areas of Belo Horizonte. Since Nov/2018 I had been an editor in the journal Docência do Ensino Superior (RDES / GIZ / UFMG) and in Jan/2020 I became Editor-in-Chief.

  • Arjun Rustagi, MD, PhD

    Arjun Rustagi, MD, PhD

    Instructor, Medicine - Infectious Diseases

    BioDr. Arjun Rustagi is an Instructor in Medicine. He is a graduate of the University of Washington Medical Scientist Training Program and Stanford's Internal Medicine Residency and Infectious Diseases Fellowship.
    He is dedicated to understanding the early immune responses to infections, and the methods pathogens use to persist despite these responses, in order to inform new prevention and treatment strategies. He studies viral pathogenesis and immunity with Dr. Catherine Blish, under whose mentorship he set up the respiratory viral biosafety level 3 (BSL3) program at Stanford in early 2020 in order to study SARS-CoV-2, contributing to several projects in SARS-CoV-2 virology including a study of intact in vitro lung tissue infection. He also protocoled the first peripheral immune profiling study of severe COVID-19. His ongoing interest is in the full spectrum of in vitro respiratory viral models, particularly those that recapitulate lung epithelium and mucosal immunity.